Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of antipsychotic drug iloperidone

A technology of iloperidone and ethyl ketone, which is applied in the field of anti-schizophrenia drugs, can solve the problems of low yield, high cost, and increased treatment of activated carbon waste residue, and achieve the effects of high yield, low cost, and shortened reaction time

Active Publication Date: 2012-06-27
HARBIN SANLIAN PHARMA CO LTD
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Can cause fetal damage, irritating and carcinogenic] dimethylformamide is used as a solvent, dimethylformamide is basically insoluble to potassium carbonate, and the reaction system is completely in a heterogeneous state, which is not conducive to 6-fluoro-3-(4 -piperidinyl)-1,2-benzisoxazole hydrochloride is rapidly dissociated and reacted, and the waste liquid generated after the reaction will cause environmental problems and needs special treatment; post-reaction treatment requires ethyl acetate extraction, and then Washing, the process is cumbersome; the reaction time is 16 hours, the cycle is long, and the yield of the refined product iloperidone is 58%, the yield is low, and the cost is high
[0009] Chinese patent CN 101768154 has improved above-mentioned patent, and its key technology is to replace DMF as reaction solvent with water, although improved the yield of iloperidone crude product (yield is 91%~92.20%), refining needs to use Recrystallization of toluene and decolorization of activated carbon, the purity of the refined product is 99.50%; the operation is troublesome, and the treatment of activated carbon waste residue is increased
Although the reaction system is in liquid phase, the intermediates participating in the reaction and the reaction medium are two phases of oil and water, and the reaction product is insoluble in water. The iloperidone crystals generated during the reaction continue to separate out and easily form agglomerates. During the process, a large number of agglomerates stick to the stirring rod and the stirring blade, and the color of the part exposed to the liquid surface turns yellow and brown, resulting in crystallization and wrapping of unreacted intermediates or impurities, which brings inconvenience to post-processing, filtration and washing, and the quality of crude products Fluctuation increases the difficulty of recrystallization and refining, and the industrialized large-scale production operation is very troublesome

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of antipsychotic drug iloperidone
  • Preparation method of antipsychotic drug iloperidone
  • Preparation method of antipsychotic drug iloperidone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] React 4-hydroxy-3-methoxyacetophenone with 1-bromo-3-chloropropane in the solvent acetone and in the presence of potassium carbonate to obtain a crude product, which is purified with isopropyl ether to obtain 1-[4-(3 -chloropropoxy)-3-methoxyphenyl]ethanone.

[0033] With 26.670g (0.110mol) reactant 1-[4-(3-chloropropoxy)-3-methoxyphenyl] ethyl ketone and 25.650g (0.100mol) reactant 6-fluoro-3-(4- Piperidinyl)-1,2-benzisoxazole hydrochloride was placed in a 1000ml reaction flask, and 41.400g (0.300mol) of anhydrous potassium carbonate, 2.490g (0.015mol) of potassium iodide and 0.05% T 320.200g of the prepared solution in an aqueous solution at a temperature of 80°C, stirred and mixed, heated to 70-85°C, and reacted with stirring for 3-5 hours. Naturally cool to room temperature, then cool down to 15±5°C and keep for 1 hour. Suction filtration, wash the filter cake twice with 150ml of water, then wash with 50ml of cold anhydrous methanol, suction filtration to dryness,...

Embodiment 2

[0035]With 26.670g (0.110mol) reactant 1-[4-(3-chloropropoxy)-3-methoxyphenyl] ethyl ketone and 25.650g (0.100mol) reactant 6-fluoro-3-(4- Piperidinyl)-1,2-benzisoxazole hydrochloride was placed in a 1000ml reaction flask, and 41.400g (0.300mol) of anhydrous potassium carbonate, 2.490g (0.015mol) of potassium iodide and 0.05% T 320.200g of the prepared solution in an aqueous solution at a temperature of 60°C, stirred and mixed, heated to 70-85°C, and reacted with stirring for 3-5 hours. Naturally cool to room temperature, then cool down to 15±5°C and keep for 1 hour. Suction filtration, wash the filter cake twice with 150ml of water, and then with 50ml of cold methanol, suction filtration to dryness, and vacuum drying at 50°C to obtain 40.00g of crude iloperidone with a yield of 93.79%. The crude product was recrystallized from methanol to obtain 37.01 g of iloperidone, with a purity of over 99.5% (HPLC normalization method), and a recrystallization yield of 92.52%.

Embodiment 3

[0037] With 26.670g (0.110mol) reactant 1-[4-(3-chloropropoxy)-3-methoxyphenyl] ethyl ketone and 25.650g (0.100mol) reactant 6-fluoro-3-(4- Piperidinyl)-1,2-benzisoxazole hydrochloride was placed in a 1000ml reaction flask, and 41.400g (0.300mol) of anhydrous potassium carbonate, 2.490g (0.015mol) of potassium iodide and 0.05% T 320.200g of the prepared solution in an aqueous solution at a temperature of 65°C, stirred and mixed, heated to 70-85°C, and reacted with stirring for 3-5 hours. Naturally cool to room temperature, then cool down to 15±5°C and keep for 1 hour. Suction filtration, wash the filter cake twice with 150ml of water, then wash with 50ml of cold methanol, suction filtration to dryness, and vacuum drying at 50°C to obtain 39.40g of crude iloperidone with a yield of 92.4%. The crude product was recrystallized from methanol to obtain 36.25 g of iloperidone, with a purity of over 99.5% (HPLC normalization method), and a recrystallization yield of 92.00%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a preparation method of a novel antipsychotic drug iloperidone, which comprises the following steps that: 6-fluoro-3-(4-piperidinyl)-1,2-benzo isoxazole hydrochloride is reacted with 1-[4-(3- chlorophenoxy)-3-methoxyphenyl]ethanone in an aqueous solution of a non-ionic surfactant by using an inorganic base as an acid binding agent and potassium iodide as a catalyst to obtain the iloperidone. The process has the advantages of high yield, high purity, good product appearance, simpleness and convenience in operation, and low cost, has no adverse impact on the environment, and is very suitable for industrial mass production.

Description

Technical field: [0001] The present invention relates to an anti-schizophrenia drug iloperidone, i.e. 1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidine A preparation method of base] propoxyl]-3-methylphenyl]ethanone belongs to the field of medicine and chemical industry. Background technique: [0002] Iloperidone has a structural formula such as formula (I), and its chemical name is 1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidine base] propoxy] -3-methoxyphenyl] ethanone. [0003] [0004] Iloperidon (Iloperidon) is a mixed dopamine D 2 / 5-hydroxytryptamine 5HT2A receptor blocker, for 5-hydroxytryptamine 5HT2A and dopamine D 2 、D 3 High affinity receptor for dopamine D 4 and serotonin 5HT6, 5HT7 and norepinephrine NEα 1 Moderate affinity for receptors, for 5HT1A, dopamine D 1 and histamine H 1 Receptor low affinity, no detectable affinity for cholinergic muscarinic receptors. iloperidone via dopamine D 2 、D 3 , 5-hydroxytryptamine 5HT1A and nor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D413/04
Inventor 陈仲强吕敏金京龙何勤
Owner HARBIN SANLIAN PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products